Industry: Biotechnology (See others in industry)
Address:Date | FilingType | Incremental Cash | Link to Raw Filing | |||
---|---|---|---|---|---|---|
2023-12-29 | New | $3,500,000 | $3,500,000 | Debt Only | 06b | SEC link |
2023-05-31 | New | $2,500,000 | $2,500,000 | Debt Only | 06b | SEC link |
2021-11-24 | New | $7,892,399 | $7,892,399 | Equity Only | 06b | SEC link |
2020-06-18 | New | $1,494,000 | $1,494,000 | Debt Only | 06b | SEC link |
2019-10-07 | Amended | $4,028,965 | $2,973,845 | Equity Only | 06b | SEC link |
2018-10-29 | New | $1,055,120 | $1,055,120 | Equity Only | 06b | SEC link |
2017-12-28 | New | $1,571,948 | $1,571,948 | Equity Only | 06b | SEC link |
2016-08-18 | New | $600,000 | $600,000 | Debt Only | 06b | SEC link |
2014-09-04 | Amended | $683,275 | $503,275 | Equity and Debt | 06b | SEC link |
2014-04-24 | New | $180,000 | $180,000 | Debt Only | 06b | SEC link |
Name | Role |
---|---|
Nicholas L Abbott | Director, Executive |
Ankit Agarwal | Director, Executive |
Robert A. Beckman | Director |
Jonathan Black | Director |
Charles J Czuprynski | Director |
Walter Dewey | Director |
Philip Foster | Director |
David Guinther | Director |
Jeff Hanson | Director |
Michael J. Schurr | Director |
Elizabeth Taylor | Executive |